Description
This Community Research Collaboration (CRC) grant for $212,000 is to conduct a pilot research project titled "Latinas¹ Experiences of Breast Cancer Treatment in Santa Cruz County". The research period will be for 18 months from September 2013 through February 2015. Meghan Halley, PhD MPH, an Assistant Research Anthropologist at the PAMF Research Institute and Carla Gomez, LCSW, the Healthy Breast Campaign's Outreach Coordinator at PAMF Santa Cruz, collaborated to develop the research proposal based on ongoing outreach work to the Latina community in Santa Cruz. Ms. Gomez currently performs outreach to low-income Latinas at local community events, community clinics and other venues to educate them on the importance of breast cancer screening and available resources for treatment and helps them navigate the screening and treatment process. The pilot study will use in-depth interviews and structured surveys to identify the underlying factors shaping low-income Latinas' breast cancer treatment experiences and decision-making in Santa Cruz County, then use community stakeholder forums to identify and prioritize changes that can have a measurable impact on breast cancer treatment for this community.
Funder
California Breast Cancer Research Program (CBCRP)
Research Topics
Related Studies
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Our objective is to examine “coverage, price, and reimbursement” for multigene tests broadly and for cancer-related indications.
Investigator: Su-Ying Liang, Ph.D.
Improving Cancer Care
Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.
Investigator: Su-Ying Liang, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Provide insights into preventive services for lung cancer. This research will contribute to the concurrent progress in lung cancer screening with LDCT.
Investigator: Jiang Li, Ph.D., MPH
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.
Investigators: External PI, Principal Investigator, Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
The goal of this project is to document incidence and risk factors for lung cancer by smoking status, among AANHPIs, focusing especially on female never smokers.
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care
To examine how EHR data can expand understanding of breast cancer pathways--screening to dx and tx.
Breast Cancer Chemoprevention in Primary Care at Geisinger
Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS
Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions
To examine the impact of the palliative care program on the patterns of ACP documentation in EHR of patients with multiple chronic conditions.
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
This study seeks to analyze of DNA and RNA isolated from donor tissues for molecular, biochemical, immunological and/or histopathological analysis.
Understanding the Experiences of Patients Undergoing Genetic Counseling and Testing for BRCA
This project investigates how patients deliberate, decide, & act upon genetic counseling & testing to determine their personal risk for breast & ovarian cancer.